Literature DB >> 18269597

Radiotherapy of classic and human immunodeficiency virus-related Kaposi's sarcoma: results in 1482 lesions.

M Caccialanza1, S Marca, R Piccinno, G Eulisse.   

Abstract

BACKGROUND: The lesions of the various forms of Kaposi's sarcoma (KS), which are relatively radiosensitive, have been treated with different modalities of radiotherapy, with heterogeneous aims and results.
OBJECTIVE: To verify the effectiveness and safety of radiotherapy on a large number of lesions endowed (classic KS) with a prolonged follow-up.
METHODS: A retrospective study was done on 711 lesions of classic KS and 771 lesions of human immunodeficiency virus (HIV)-related KS, treated with traditional X-ray therapy.
RESULTS: In classic KS, a cure rate of 98.7% resulted after 13.5 years from the end of radiotherapy. In three lesions (0.42%) in the same patient, an acute radiodermatitis occurred after traumatic action. In HIV-related KS, a complete remission was obtained in 91.43% of the lesions, partial remission in 6.74% and non-response in 0.51% at 1 to 46 months from the end of radiotherapy.
CONCLUSION: Radiotherapy showed to be a safe and effective method, with relevant importance in the therapeutic strategy of KS.

Entities:  

Mesh:

Year:  2008        PMID: 18269597     DOI: 10.1111/j.1468-3083.2007.02405.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  10 in total

1.  Recurrent Classical Type of Kaposi's Sarcoma Treated by Interferon-alpha.

Authors:  Min Ju Kang; Tae Yoon Kim
Journal:  Ann Dermatol       Date:  2008-09-30       Impact factor: 1.444

Review 2.  Radiotherapy for patients with the human immunodeficiency virus: are special precautions necessary?

Authors:  Nadine Housri; Robert Yarchoan; Aradhana Kaushal
Journal:  Cancer       Date:  2010-01-15       Impact factor: 6.860

Review 3.  Treatment for Kaposi sarcoma herpesvirus: great challenges with promising accomplishments.

Authors:  Ravit Arav-Boger
Journal:  Virus Genes       Date:  2009-01-13       Impact factor: 2.332

4.  Classic Kaposi's sarcoma in Morocco: clinico-epidemiological study at the National Institute of Oncology.

Authors:  Hassan Errihani; Narjisse Berrada; Soundouss Raissouni; Fadoi Rais; Hind Mrabti; Ghizlane Rais
Journal:  BMC Dermatol       Date:  2011-11-11

Review 5.  The Role of Radiotherapy in Treating Kaposi's Sarcoma in HIV Infected Patients.

Authors:  Laurent Quéro; Romain Palich; Marc-Antoine Valantin
Journal:  Cancers (Basel)       Date:  2022-04-10       Impact factor: 6.639

Review 6.  Oral complications of HIV disease.

Authors:  Jair C Leao; Camila M B Ribeiro; Alessandra A T Carvalho; Cristina Frezzini; Stephen Porter
Journal:  Clinics (Sao Paulo)       Date:  2009-05       Impact factor: 2.365

7.  Role of radiotherapy in local control of non-AIDS associated Kaposi's sarcoma patients in Korea: a single institution experience.

Authors:  Ji Hyun Chang; Il Han Kim
Journal:  Radiat Oncol J       Date:  2012-12-31

8.  Mucosal Kaposi sarcoma, a Rare Cancer Network study.

Authors:  Juliette Thariat; Youlia Kirova; Terence Sio; Olivier Choussy; Hans Vees; Ulrich Schick; Gilles Poissonnet; Esma Saada; Antoine Thyss; Robert C Miller
Journal:  Rare Tumors       Date:  2012-10-17

9.  Case Report: Pulmonary Kaposi Sarcoma in a non-HIV patient.

Authors:  Arber Kodra; Maciej Walczyszyn; Craig Grossman; Daniel Zapata; Tarak Rambhatla; Bushra Mina
Journal:  F1000Res       Date:  2015-10-07

10.  Oral Kaposi Sarcoma in HIV-seronegative Saudi patient: Literature review and case report.

Authors:  Asmaa Faden; Manal AlSheddi; Mohammed AlKindi; Lama Alabdulaaly
Journal:  Saudi Dent J       Date:  2017-05-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.